table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Pediatric Drugs Market Size Analysis from 2023 to 2028
1.5.1 Global Pediatric Drugs Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Pediatric Drugs Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Pediatric Drugs Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Pediatric Drugs Industry Impact
Chapter 2 Global Pediatric Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pediatric Drugs (Volume and Value) by Type
2.1.1 Global Pediatric Drugs Consumption and Market Share by Type (2017-2022)
2.1.2 Global Pediatric Drugs Revenue and Market Share by Type (2017-2022)
2.2 Global Pediatric Drugs (Volume and Value) by Application
2.2.1 Global Pediatric Drugs Consumption and Market Share by Application (2017-2022)
2.2.2 Global Pediatric Drugs Revenue and Market Share by Application (2017-2022)
2.3 Global Pediatric Drugs (Volume and Value) by Regions
2.3.1 Global Pediatric Drugs Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Pediatric Drugs Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Pediatric Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Pediatric Drugs Consumption by Regions (2017-2022)
4.2 North America Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
4.10 South America Pediatric Drugs Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Pediatric Drugs Market Analysis
5.1 North America Pediatric Drugs Consumption and Value Analysis
5.1.1 North America Pediatric Drugs Market Under COVID-19
5.2 North America Pediatric Drugs Consumption Volume by Types
5.3 North America Pediatric Drugs Consumption Structure by Application
5.4 North America Pediatric Drugs Consumption by Top Countries
5.4.1 United States Pediatric Drugs Consumption Volume from 2017 to 2022
5.4.2 Canada Pediatric Drugs Consumption Volume from 2017 to 2022
5.4.3 Mexico Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 6 East Asia Pediatric Drugs Market Analysis
6.1 East Asia Pediatric Drugs Consumption and Value Analysis
6.1.1 East Asia Pediatric Drugs Market Under COVID-19
6.2 East Asia Pediatric Drugs Consumption Volume by Types
6.3 East Asia Pediatric Drugs Consumption Structure by Application
6.4 East Asia Pediatric Drugs Consumption by Top Countries
6.4.1 China Pediatric Drugs Consumption Volume from 2017 to 2022
6.4.2 Japan Pediatric Drugs Consumption Volume from 2017 to 2022
6.4.3 South Korea Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 7 Europe Pediatric Drugs Market Analysis
7.1 Europe Pediatric Drugs Consumption and Value Analysis
7.1.1 Europe Pediatric Drugs Market Under COVID-19
7.2 Europe Pediatric Drugs Consumption Volume by Types
7.3 Europe Pediatric Drugs Consumption Structure by Application
7.4 Europe Pediatric Drugs Consumption by Top Countries
7.4.1 Germany Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.2 UK Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.3 France Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.4 Italy Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.5 Russia Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.6 Spain Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.7 Netherlands Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.8 Switzerland Pediatric Drugs Consumption Volume from 2017 to 2022
7.4.9 Poland Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 8 South Asia Pediatric Drugs Market Analysis
8.1 South Asia Pediatric Drugs Consumption and Value Analysis
8.1.1 South Asia Pediatric Drugs Market Under COVID-19
8.2 South Asia Pediatric Drugs Consumption Volume by Types
8.3 South Asia Pediatric Drugs Consumption Structure by Application
8.4 South Asia Pediatric Drugs Consumption by Top Countries
8.4.1 India Pediatric Drugs Consumption Volume from 2017 to 2022
8.4.2 Pakistan Pediatric Drugs Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Pediatric Drugs Market Analysis
9.1 Southeast Asia Pediatric Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Pediatric Drugs Market Under COVID-19
9.2 Southeast Asia Pediatric Drugs Consumption Volume by Types
9.3 Southeast Asia Pediatric Drugs Consumption Structure by Application
9.4 Southeast Asia Pediatric Drugs Consumption by Top Countries
9.4.1 Indonesia Pediatric Drugs Consumption Volume from 2017 to 2022
9.4.2 Thailand Pediatric Drugs Consumption Volume from 2017 to 2022
9.4.3 Singapore Pediatric Drugs Consumption Volume from 2017 to 2022
9.4.4 Malaysia Pediatric Drugs Consumption Volume from 2017 to 2022
9.4.5 Philippines Pediatric Drugs Consumption Volume from 2017 to 2022
9.4.6 Vietnam Pediatric Drugs Consumption Volume from 2017 to 2022
9.4.7 Myanmar Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 10 Middle East Pediatric Drugs Market Analysis
10.1 Middle East Pediatric Drugs Consumption and Value Analysis
10.1.1 Middle East Pediatric Drugs Market Under COVID-19
10.2 Middle East Pediatric Drugs Consumption Volume by Types
10.3 Middle East Pediatric Drugs Consumption Structure by Application
10.4 Middle East Pediatric Drugs Consumption by Top Countries
10.4.1 Turkey Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.3 Iran Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.5 Israel Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.6 Iraq Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.7 Qatar Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.8 Kuwait Pediatric Drugs Consumption Volume from 2017 to 2022
10.4.9 Oman Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 11 Africa Pediatric Drugs Market Analysis
11.1 Africa Pediatric Drugs Consumption and Value Analysis
11.1.1 Africa Pediatric Drugs Market Under COVID-19
11.2 Africa Pediatric Drugs Consumption Volume by Types
11.3 Africa Pediatric Drugs Consumption Structure by Application
11.4 Africa Pediatric Drugs Consumption by Top Countries
11.4.1 Nigeria Pediatric Drugs Consumption Volume from 2017 to 2022
11.4.2 South Africa Pediatric Drugs Consumption Volume from 2017 to 2022
11.4.3 Egypt Pediatric Drugs Consumption Volume from 2017 to 2022
11.4.4 Algeria Pediatric Drugs Consumption Volume from 2017 to 2022
11.4.5 Morocco Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 12 Oceania Pediatric Drugs Market Analysis
12.1 Oceania Pediatric Drugs Consumption and Value Analysis
12.2 Oceania Pediatric Drugs Consumption Volume by Types
12.3 Oceania Pediatric Drugs Consumption Structure by Application
12.4 Oceania Pediatric Drugs Consumption by Top Countries
12.4.1 Australia Pediatric Drugs Consumption Volume from 2017 to 2022
12.4.2 New Zealand Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 13 South America Pediatric Drugs Market Analysis
13.1 South America Pediatric Drugs Consumption and Value Analysis
13.1.1 South America Pediatric Drugs Market Under COVID-19
13.2 South America Pediatric Drugs Consumption Volume by Types
13.3 South America Pediatric Drugs Consumption Structure by Application
13.4 South America Pediatric Drugs Consumption Volume by Major Countries
13.4.1 Brazil Pediatric Drugs Consumption Volume from 2017 to 2022
13.4.2 Argentina Pediatric Drugs Consumption Volume from 2017 to 2022
13.4.3 Columbia Pediatric Drugs Consumption Volume from 2017 to 2022
13.4.4 Chile Pediatric Drugs Consumption Volume from 2017 to 2022
13.4.5 Venezuela Pediatric Drugs Consumption Volume from 2017 to 2022
13.4.6 Peru Pediatric Drugs Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Pediatric Drugs Consumption Volume from 2017 to 2022
13.4.8 Ecuador Pediatric Drugs Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Pediatric Drugs Business
14.1 Abbott Laboratories
14.1.1 Abbott Laboratories Company Profile
14.1.2 Abbott Laboratories Pediatric Drugs Product Specification
14.1.3 Abbott Laboratories Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Bayer
14.2.1 Bayer Company Profile
14.2.2 Bayer Pediatric Drugs Product Specification
14.2.3 Bayer Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Boehringer Ingelheim
14.3.1 Boehringer Ingelheim Company Profile
14.3.2 Boehringer Ingelheim Pediatric Drugs Product Specification
14.3.3 Boehringer Ingelheim Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Bristol-Myers Squibb
14.4.1 Bristol-Myers Squibb Company Profile
14.4.2 Bristol-Myers Squibb Pediatric Drugs Product Specification
14.4.3 Bristol-Myers Squibb Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Colgate Oral Pharmaceuticals
14.5.1 Colgate Oral Pharmaceuticals Company Profile
14.5.2 Colgate Oral Pharmaceuticals Pediatric Drugs Product Specification
14.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Eli Lilly
14.6.1 Eli Lilly Company Profile
14.6.2 Eli Lilly Pediatric Drugs Product Specification
14.6.3 Eli Lilly Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Forest Laboratories
14.7.1 Forest Laboratories Company Profile
14.7.2 Forest Laboratories Pediatric Drugs Product Specification
14.7.3 Forest Laboratories Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Genentech
14.8.1 Genentech Company Profile
14.8.2 Genentech Pediatric Drugs Product Specification
14.8.3 Genentech Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 GlaxoSmithKline
14.9.1 GlaxoSmithKline Company Profile
14.9.2 GlaxoSmithKline Pediatric Drugs Product Specification
14.9.3 GlaxoSmithKline Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Johnson & Johnson
14.10.1 Johnson & Johnson Company Profile
14.10.2 Johnson & Johnson Pediatric Drugs Product Specification
14.10.3 Johnson & Johnson Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 MedImmune
14.11.1 MedImmune Company Profile
14.11.2 MedImmune Pediatric Drugs Product Specification
14.11.3 MedImmune Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Merck
14.12.1 Merck Company Profile
14.12.2 Merck Pediatric Drugs Product Specification
14.12.3 Merck Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Novartis Pharmaceuticals
14.13.1 Novartis Pharmaceuticals Company Profile
14.13.2 Novartis Pharmaceuticals Pediatric Drugs Product Specification
14.13.3 Novartis Pharmaceuticals Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Novo Nordisk
14.14.1 Novo Nordisk Company Profile
14.14.2 Novo Nordisk Pediatric Drugs Product Specification
14.14.3 Novo Nordisk Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Pfizer
14.15.1 Pfizer Company Profile
14.15.2 Pfizer Pediatric Drugs Product Specification
14.15.3 Pfizer Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Pharmacia
14.16.1 Pharmacia Company Profile
14.16.2 Pharmacia Pediatric Drugs Product Specification
14.16.3 Pharmacia Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Roche
14.17.1 Roche Company Profile
14.17.2 Roche Pediatric Drugs Product Specification
14.17.3 Roche Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 Schering-Plough
14.18.1 Schering-Plough Company Profile
14.18.2 Schering-Plough Pediatric Drugs Product Specification
14.18.3 Schering-Plough Pediatric Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Pediatric Drugs Market Forecast (2023-2028)
15.1 Global Pediatric Drugs Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Pediatric Drugs Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Pediatric Drugs Value and Growth Rate Forecast (2023-2028)
15.2 Global Pediatric Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Pediatric Drugs Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Pediatric Drugs Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Pediatric Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Pediatric Drugs Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Pediatric Drugs Consumption Forecast by Type (2023-2028)
15.3.2 Global Pediatric Drugs Revenue Forecast by Type (2023-2028)
15.3.3 Global Pediatric Drugs Price Forecast by Type (2023-2028)
15.4 Global Pediatric Drugs Consumption Volume Forecast by Application (2023-2028)
15.5 Pediatric Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
